73 related articles for article (PubMed ID: 8622867)
1. Analysis of human c-Abl tyrosine kinase activity and regulation in S. pombe.
Walkenhorst J; Goga A; Witte ON; Superti-Furga G
Oncogene; 1996 Apr; 12(7):1513-20. PubMed ID: 8622867
[TBL] [Abstract][Full Text] [Related]
2. A functional screen for regulators of the c-Abl protein tyrosine kinase.
Moro M; Walkenhorst J; Goga A; Witte ON; Superti-Furga G
Leukemia; 1997 Apr; 11 Suppl 3():313-5. PubMed ID: 9209375
[TBL] [Abstract][Full Text] [Related]
3. An intramolecular SH3-domain interaction regulates c-Abl activity.
Barilá D; Superti-Furga G
Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
Jung JH; Pendergast AM; Zipfel PA; Traugh JA
Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
[TBL] [Abstract][Full Text] [Related]
5. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.
Jackson PK; Paskind M; Baltimore D
Oncogene; 1993 Jul; 8(7):1943-56. PubMed ID: 8510937
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for the efficient regulation of the Src protein tyrosine kinase by Csk.
Koegl M; Courtneidge SA; Superti-Furga G
Oncogene; 1995 Dec; 11(11):2317-29. PubMed ID: 8570183
[TBL] [Abstract][Full Text] [Related]
8. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
Mysliwiec T; Perego R; Kruh GD
Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720
[TBL] [Abstract][Full Text] [Related]
9. Sequences within the first exon of BCR inhibit the activated tyrosine kinases of c-Abl and the Bcr-Abl oncoprotein.
Liu J; Wu Y; Arlinghaus RB
Cancer Res; 1996 Nov; 56(22):5120-4. PubMed ID: 8912843
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human c-Abl tyrosine kinase activity in Xenopus oocytes and acceleration of progesterone-induced G2/M transition by oncogenic forms.
Dorey K; Barilá D; Gavin AC; Nebreda AR; Superti-Furga G
Biol Chem; 1999 Feb; 380(2):223-30. PubMed ID: 10195429
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase.
Dorey K; Engen JR; Kretzschmar J; Wilm M; Neubauer G; Schindler T; Superti-Furga G
Oncogene; 2001 Dec; 20(56):8075-84. PubMed ID: 11781820
[TBL] [Abstract][Full Text] [Related]
12. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
Nagar B; Hantschel O; Seeliger M; Davies JM; Weis WI; Superti-Furga G; Kuriyan J
Mol Cell; 2006 Mar; 21(6):787-98. PubMed ID: 16543148
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
Ren SY; Xue F; Feng J; Skorski T
Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
[TBL] [Abstract][Full Text] [Related]
15. Non-receptor tyrosine kinases c-Abl and Arg regulate the activity of C/EBPbeta.
Li X; Liu X; Wang G; Zhu X; Qu X; Li X; Yang Y; Peng L; Li C; Li P; Huang W; Ma Q; Cao C
J Mol Biol; 2009 Aug; 391(4):729-43. PubMed ID: 19563810
[TBL] [Abstract][Full Text] [Related]
16. F-actin-binding domain of c-Abl regulates localized phosphorylation of C3G: role of C3G in c-Abl-mediated cell death.
Mitra A; Radha V
Oncogene; 2010 Aug; 29(32):4528-42. PubMed ID: 20581864
[TBL] [Abstract][Full Text] [Related]
17. Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfolded.
Buffa P; Manzella L; Consoli ML; Messina A; Vigneri P
Proteins; 2007 Apr; 67(1):1-11. PubMed ID: 17211892
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
[TBL] [Abstract][Full Text] [Related]
19. A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-gamma1.
Plattner R; Irvin BJ; Guo S; Blackburn K; Kazlauskas A; Abraham RT; York JD; Pendergast AM
Nat Cell Biol; 2003 Apr; 5(4):309-19. PubMed ID: 12652307
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
Oda T; Kujovich J; Reis M; Newman B; Druker BJ
Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
